After the blizzard has its way with the Northeast and moves on, what is the best way to start clearing snow if you've had heart issues?
Roche is taking a majority stake in U.S.-based Foundation Medicine in a deal worth $1.03 billion that the Swiss pharmaceutical company says will help it to develop new treatment options for cancer patients.
If your "common cold" has been hanging around for more than a week, it may not be a cold at all. It might actually be an allergy disguised as a cold.
(Medical Xpress)—Cardiac deaths during this week's storm have occurred not just while people are shoveling but while they have been using snowblowers as well.
The University of Toronto, Chematria and IBM are combining forces in a quest to find new treatments for the Ebola virus.
Officials at a life sciences startup based on a Purdue University innovation say their company could help cardiologists improve the diagnosis of heart disease, which the World Health Organization listed as ...
French drugmaker Sanofi sacked its CEO Wednesday following a board room rift over his way of handling one of France's largest publicly traded companies.
Dartmouth College researchers are going to market with the first-ever sensor that detects secondhand and thirdhand tobacco and marijuana smoke in real time.
Leaders of England's state-funded National Health Service (NHS) warned on Thursday that billions of pounds in extra funds were needed to maintain patient care, laying down the gauntlet to politicians ahead of May's general ...
(HealthDay)—For the second year running, physician turnover remains at the highest rate since 2005, according to a report published by the American Medical Group Association (AMGA).
(HealthDay)—Patient reviews indicate that the attributes most valued in physicians include interpersonal skills and bedside manner, according to a report published online July 16 by Vitals.
Laws in New York and Chicago making electronic cigarettes subject to the same regulations as tobacco are taking effect, and their sellers and users are steadfast in their opposition.
US drugs giant Pfizer wants a blockbuster merger with British rival AstraZeneca that will fuel cancer research, revealing on Monday that an informal approach worth almost $100 billion had been rejected.
The Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal (UdeM), in collaboration with the Maisonneuve-Rosemont Hospital's Quebec Leukemia Cell Bank, recently achieved a ...
A new book co-authored by a Virginia Commonwealth University professor offers the first in-depth look at how people with dyslexia and other learning disabilities (LD) achieve high levels of success.